Cure8 research brief
A non-invasive MRI method that correlates with histology and endoscopic scores could reduce the need for frequent colonoscopy for assessing IBD activity and help monitor treatment response, especially when endoscopy is difficult or risky.
Clinicians who manage IBD (gastroenterologists, radiologists), researchers studying imaging biomarkers in IBD, and adult patients with Crohn’s disease or ulcerative colitis interested in non-invasive monitoring options.
The study used a 1.5 T MRI with DWI at b = 800 s/mm2 and calculated apparent diffusion coefficient (ADC) values for diseased bowel segments. ADC values were lower with greater inflammatory activity by histology in both Crohn’s and UC, and correlated with MES in the UC subgroup.
The authors report an ROC-derived ADC cutoff that separated mild from moderate-to-severe inflammation with about 75% sensitivity and 82% specificity in this cohort.
How people might use this: The paper suggests DWI MREC could serve as a non-invasive adjunct or alternative to endoscopy for assessing and monitoring intestinal inflammation in some settings (for example when endoscopy is risky or poorly tolerated), but it does not replace clinical judgment or established protocols.
Abstract-level summary only. Study size was modest (50 patients) and from a single center; ADC cutoff and performance require validation across centers, MRI field strengths, and imaging protocols before being used routinely.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Distinguishing UC from Crohn’s colitis can be challenging but affects long-term management and surveillance. A histologic feature—homogeneity versus heterogeneity of epithelial lesions across biopsies—might help improve...
People with IBD have a higher lifetime risk of colorectal cancer; updated UK guidelines give clinicians and patients evidence-based recommendations on when and how to do surveillance colonoscopy to detect precancerous...
A non-invasive test (intestinal ultrasound) that predicts whether patients stay on biologic therapy could reduce the need for frequent endoscopy and help guide monitoring decisions.
